Lin RC - Search Results

1

Phage Biobank: Present Challenges and Future Perspectives.

Lin RC, Sacher JC, Ceyssens PJ, Zheng J, Khalid A, Iredell JR; Australian Phage Biobanking Network. Lin RC, et al. Curr Opin Biotechnol. 2021 Apr;68:221-230. doi: 10.1016/j.copbio.2020.12.018. Epub 2021 Feb 10. Curr Opin Biotechnol. 2021. PMID: 33581425 Review.

2

Bacteriophage Therapy of Ventilator-associated Pneumonia and Empyema Caused by Pseudomonas aeruginosa.

Maddocks S, Fabijan AP, Ho J, Lin RCY, Ben Zakour NL, Dugan C, Kliman I, Branston S, Morales S, Iredell JR. Maddocks S, et al. Am J Respir Crit Care Med. 2019 Nov 1;200(9):1179-1181. doi: 10.1164/rccm.201904-0839LE. Am J Respir Crit Care Med. 2019. PMID: 31437402 No abstract available.

3

Polyclonal Staphylococcus aureus Bacteremia.

Fabijan AP, Ben Zakour NL, Ho J, Lin RCY, Iredell J; Westmead Bacteriophage Therapy Team (WBTT) and AmpliPhi Biosciences Corporation. Fabijan AP, et al. Ann Intern Med. 2019 Dec 17;171(12):940-941. doi: 10.7326/L19-0369. Epub 2019 Sep 17. Ann Intern Med. 2019. PMID: 31525739 No abstract available.

4

Phage therapy for severe bacterial infections: a narrative review.

Petrovic Fabijan A, Khalid A, Maddocks S, Ho J, Gilbey T, Sandaradura I, Lin RC, Ben Zakour N, Venturini C, Bowring B, Iredell JR. Petrovic Fabijan A, et al. Among authors: lin rc. Med J Aust. 2020 Apr;212(6):279-285. doi: 10.5694/mja2.50355. Epub 2019 Oct 6. Med J Aust. 2020. PMID: 31587298 Free PMC article. Review.

5

Characterizing the role of porin mutations in susceptibility of beta lactamase producing Klebsiella pneumoniae isolates to ceftaroline and ceftaroline-avibactam.

Khalid A, Lubián AF, Ma L, Lin RCY, Iredell JR. Khalid A, et al. Int J Infect Dis. 2020 Apr;93:252-257. doi: 10.1016/j.ijid.2020.02.005. Epub 2020 Feb 13. Int J Infect Dis. 2020. PMID: 32061861 Free article.

6

Safety of bacteriophage therapy in severe Staphylococcus aureus infection.

Petrovic Fabijan A, Lin RCY, Ho J, Maddocks S, Ben Zakour NL, Iredell JR; Westmead Bacteriophage Therapy Team. Petrovic Fabijan A, et al. Nat Microbiol. 2020 Mar;5(3):465-472. doi: 10.1038/s41564-019-0634-z. Epub 2020 Feb 17. Nat Microbiol. 2020. PMID: 32066959 Clinical Trial.

7

Publisher Correction: Safety of bacteriophage therapy in severe Staphylococcus aureus infection.

Petrovic Fabijan A, Lin RCY, Ho J, Maddocks S, Ben Zakour NL, Iredell JR; Westmead Bacteriophage Therapy Team. Petrovic Fabijan A, et al. Nat Microbiol. 2020 Apr;5(4):652. doi: 10.1038/s41564-020-0698-9. Nat Microbiol. 2020. PMID: 32139910

8

A Phage Therapy Guide for Clinicians and Basic Scientists: Background and Highlighting Applications for Developing Countries.

Khalid A, Lin RCY, Iredell JR. Khalid A, et al. Front Microbiol. 2021 Feb 11;11:599906. doi: 10.3389/fmicb.2020.599906. eCollection 2020. Front Microbiol. 2021. PMID: 33643225 Free PMC article. Review.

9

Bacterial lysis, autophagy and innate immune responses during adjunctive phage therapy in a child.

Khatami A, Lin RCY, Petrovic-Fabijan A, Alkalay-Oren S, Almuzam S, Britton PN, Brownstein MJ, Dao Q, Fackler J, Hazan R, Horne B, Nir-Paz R, Iredell JR. Khatami A, et al. EMBO Mol Med. 2021 Sep 7;13(9):e13936. doi: 10.15252/emmm.202113936. Epub 2021 Aug 9. EMBO Mol Med. 2021. PMID: 34369652 Free PMC article.

10

Data to Power Precision Phage Therapy: A Look at the Phage Directory-Phage Australia Partnership.

Sacher JC, Zheng J, Lin RCY. Sacher JC, et al. Phage (New Rochelle). 2022 Jun 1;3(2):112-115. doi: 10.1089/phage.2022.29030.jcs. Epub 2022 Jun 16. Phage (New Rochelle). 2022. PMID: 36157289 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

461 results

Search Page